SCHEMBL4123470

SCHEMBL4123470

CCOc1cccc(C(O)c2cc(Cl)ccc2NCc2ccc(OC)cc2OC)c1OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
LMNA P02545 5/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
GAA P10253 3/20 0.42
MAPT P10636 3/20 0.42
THRB P10828 2/20 0.42
BLM P54132 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
XBP1 P17861 1/20 0.42
ALOX12 P18054 1/20 0.42
HTT P42858 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 8/20 0.39
CYP3A4 P08684 8/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4123181 0.97 TAS1R3 (0.42) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL4121857 0.91 TAS1R3 (0.44) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL4123362 0.89 ALDH1A1 (0.44) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL4119617 0.88 TAS1R3 (0.49) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL4123383 0.88 TAS1R3 (0.43) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL4122265 0.88 TAS1R3 (0.44) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL4298760 0.87 TAS1R3 (0.42) ALDH1A1LMNAGAAMAPTALOX12
SCHEMBL4113260 0.87 TAS1R3 (0.42) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL4111042 0.87 TSHR (0.42) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL4116863 0.87 TAS1R3 (0.44) ALDH1A1LMNAKMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR ALDH1A1 1587/4885LMNA 1109/4885KMT2A 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.